The effect of β-tubulin-specific antisense oligonucleotide encapsulated in different cationic liposomes on the supression of intracellular L. Donovani parasites in vitro by Dasgupta, Dalia et al.
J. Biochem. 132, 23-27 (2002)
The Effect of 3-Tubulin-Specific Antisense Oligonucleotide
Encapsulated in Different Cationic Liposomes on tHe Supression of
Intracellular L. Donovani Parasites In Vitro1
Dalia Dasgupta,* Samit Adhya,1 and Mukul Kumar Basu<>2
Divisions of Biomembrane and ^ Genetic Engineering, Indian Institute of Chemical Biology, 4, Raja S.C. Mullick
Road, Calcutta-700032, India
Received December 10, 2001; accepted March 26, 2002
An antisense oligonucleotide (20 mer) targeted to the parasite p-tubulin gene and encap-
sulated in cationic liposomes, was used to test its antileishmanial activity in vitro. Cat-
ionic liposomes containing dioleyl trimethyl ammonium propane (DOTAP) were found
to have higher antileishmanial activity (88% at 4 JJLM oligonucleotide) compared to two
other liposomes with stearyl amine (SA) and cetyl trimethyl ammonium bromide (CTAB)
as cations. Dot-blot experiments were performed to analyse the expression of p-tubulin
mRNA using p-tubulin-specific radiolabelled DNA as a probe. When compared with
their respective controls, P-tubulin-specific gene expression was found to be diminished
by treatment with a specific antisense oligonucleotide encapsulated in cationic lipo-
somes (CTAB:DOPE) in a concentration-dependent manner. These experiments show
that antisense oligonucleotides targeted to the p-tubulin gene of Leishmania donovani
inhibit p-tubulin synthesis leading to the arrest of multiplication of intracellular para-
sites.
Key words: antisense oligonucleotides, p-tubulin, cationic liposomes, leishmania, RNA
expression.
The clinical applications of antisense oligonucleotides are of
particular interest due to their antiproliferative, antiviral,
and antiparasitic properties (1). Antisense molecules are
designed to modulate the expression of specific proteins by
interfering with transcription, mRNA maturation and/or
translation (2).
In case of leishmaniasis, the serious host toxicity of con-
ventional drugs along with the evolving phenomenon of
drug resistance has prompted the need for a "perfect" medi-
cation without side effects. Antisense oligonucleotides, with
their exquisite specificity and high affinity for target sites
and ease of design, promise to provide highly specific tools
for overcoming many of the drawbacks of conventional che-
motherapy (1). Selection of the target site is very important
as antisense molecules are designed to modulate the ex-
pression of a specific gene. As reported, an attractive target
site for the antisense inhibition of leishmania and other ki-
netoplastide protozoa is the 39-nucleotide miniexon se-
quence universally present at the 5' end of all cytoplasmic
mRNAs. Antisense oligonucleotides complementary to the
miniexon sequence have been shown to inhibit L. amazon-
ensis (3) and Leishmania donovani (4) growth in macroph-
ages in vitro. Moreover, we have shown that encapsulation
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in cationic liposomes (CTAB: DPPE) targeted to the mini-
exon sequence has increased the leishmanicidal activity of
the antisense oligonucleotide (4).
In this study, we selected the p-tubulin gene of Leishma-
nia as the target site for antisense therapy. Tubulins are
major cytoskeletal proteins in kinetoplastid protozoa, and
play an important part in a number of cellular structures
such as the cytoskeleton, pellicle, mitotic spindle, and fla-
gellum. The microtubular system has been used as a poten-
tial target for drugs in curative and preventive chemo-
therapy of trypanosomiasis and leishmaniasis (5, 6). In this
study, we investigated the effect of different cationic lipo-
some-encapsulated anti-p-tubulin oligonucleotides on the
suppression of intracelullar L. donovani growth and P-
tubulin mRNA expression in vitro.
EXPERIMENTAL PROCEDURES
Materials—Dioleylphosphatidylethanolamine (DOPE),
cetyltrimethyl ammonium bromide (CTAB), stearylamine
(SA), dioleyl trimethyl ammonium propane (DOTAP), agar-
ose, acrylamide, trizma, sodium dodecylsulfate, ammonium
persulfate, chloroform, methanol, phenol, EDTA, p-mercap-
toethanol, isoamyl alcohol, and isopropanol were purchased
from Sigma Chemicals. Medium M199, RPMI 1640, heat
inactivated fetal bovine serum, penicillin, streptomycin,
and gentamycin were from Gibco Laboratories. Absolute
ethanol was purchased from E-March. All other reagents
were of analytical grade.
Oligonucleotides—Antisense oligonucleotide complemen-
tary to positions 1-20 of the L. donovani p-tubulin gene
(5'CAGGAAACGATCACGCAT 3') and the corresponding
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sense oligonucleotide (5'ATGCGTGAGATCGTTTCGTG3')
were synthesized by Bangalore Genei (Pvt), Peenya, India.
Crude oligonucleotides were purified by electrophoresis in
denaturing 15% polyacrylamide gels. Oligonucleotides were
32P-labeled using T4 polynucleotide kinase, and quantified
by adsorption on DEAE paper, as described (4).
Preparation of Cationic Liposomes—Cationic liposomes
using DOPE and different cations such as CTAB, SA,
DOTAP in a molar ratio of 4:1 were prepared a using stan-
dard protocol (4, 7). The liposomal suspension was passed
through Millipore filter paper for sterilization and the size
of the vesicles was found to be -200 nm in diameter.
Encapsulation of Labeled Oligonucleotide into Liposomes
and Assessment of Encapsulation—The purified oligonucle-
otides were first labeled with [7-32P]ATP using a standard
protocol (4). To the cationic liposomes prepared as described
above, labeled oligonucleotides were added during swelling
of the lipid film with PBS. The mixture was then sonicated
and centrifuged at 100,000 xg. Radioactivity present in the
washed pellet was then measured. To calculate the percent-
age encapsulation, the liposomes were treated with pancre-
atic DNase I (50 units/ml) to remove the surface associated
radioactivity. The total amount of encapsulated and sur-
face-associated oligonucleotide was found to be 30%
whereas 10% of oligonucleotide was encapsulated. The oli-
gonucleotide to lipid molar ratio was calculated to be
around 1:670.
Parasites—The pathogenic strain of L. donovani AG83
(MHOM/IN/1983/AG83) was used in this study. The prepa-
ration and maintenance of the amastigote and promastig-
ote forms of the parasites were as described (4).
Macrophage Culture and Infection with Parasites—The
TG-elicited peritoneal macrophages from swiss mice were
isolated and plated on coverslips for 2 h at 37°C to obtain a
monolayer of macrophages. The macrophage monolayer
was challenged with L. donovani promastigotes at a ratio of
(1:20) and incubated for 2 h at 37°C.
Treatment of Infected Macrophages with Oligonucle-
otides—To the infected macrophages, p-tubulin-specific
free antisense oligonucleotides, complementary free sense
oligonucleotides and different cationic liposome-encapsu-
lated antisense oligonucleotides at concentrations of 1^1
tun were added and the mixtures were kept for 24 h at
37°C, and then in oligonucleotide-free medium for 18 h at
37°C in a CO2 incubator. The cells were then either pro-
cessed for the microscopic analysis of the fate of the intrac-
ellular parasites, or total RNA was isolated to analyse the
(3-tubulin RNA levels using a standard protocol. The viabil-
ity of macrophages in presence of antisense oligonucle-
otides was examined by the trypan blue exclusion test..
RNA Isolation—Tolal RNA from infected macrophages
and antisense oligonucleotide—treated infected macroph-
ages was isolated using the general phenolchloroform
method (S). To 100 JJJ of PCV (packed cell volume), 5 vol-
umes of solution D (containing 4 M guanidium isothiocyan-
ate, 50 mM Tris (pH 7.5), 10 mM EDTA, 2% sarcosyl) and
18 |xl p-mercaptoethanol were added and mixed well. To
this, 1 volume of 1 M NaAC (pH 4.0) and 5 volumes of phe-
nohHgO were added, mixed well, and the mixtures were
kept on ice for 10 min. To this, chloroform:isoamylalcohol
(24:1 v/v) was added, and the mixtures were vortexed and
kept on ice for 10 min. Then the mixtures were centrifuged
at 10,000 rpm for 15 min at 4°C, and the supernatants
were collected. To the supernatants, equal volumes of iso-
propanol were added and the mixtures were kept at -20°C
overnight. The next day, the solutions were centrifuged at
10 K for 15 min at 4°C. The pellets were washed with 70%
alcohol, dried , dissolved in DEPC water and kept at -70°C
until use. The total RNA from L. donovani promastigotes
was prepared in the same way. The OD of 1 JJLI RNA was
checked at 260 and 280 nm; its presence was confirmed by
electrophoresis in 1% native agarose gels (data not shown).
Dot-Blot Analysis—For Dot-Blot analysis, the total RNA
from infected macrophages, free and cationic liposome-
encapsulated antisense oligonucleotide-treated infected
macrophages, normal macrophages, and L. donovani para-
sites was spotted on a Hybond nylon membrane at a fixed
concentration. The membrane was dried, UV crosslinked
and kept at 4°C before hybridization.
Preparation of/i-Tubulin Probe DNA—Plasmid PLDBT-1
containing the (3-tubulin gene inserted in plasmid pUC 8
was isolated from Escherichia coli cells using a standard
method (9). The coding region of the (3-tubulin gene (540
bp) insert was recovered from the plasmid DNA (pUC8)
with restriction enzymes Hindlll and Xhol and isolated by
electrophoresis followed by electroelution and purification.
Labeling of the DNA Probe—The isolated fragment was
labeled with [a-32P]dTTP by the random priming method
(9).
Hybridization with Labeled (3-Tubulin DNA Probe—The
UV-crosslinked spots of RNA on the Hybond nylon mem-
brane (dot-blot analysis) were prehybridized for 3^1 h at
42°C in 50% deionized formamide, 5x SSC, 5x Denhardt
solution, 20 mM sodium phosphate, pH 7.0, 0.1% SDS, and
1 ml of heat chilled calf thymus DNA (2 mg/ml). Hybridiza-
tion was performed in the same solution, additionally con-
taining a-32P-labeled denatured pT, DNA probe at 105-106
cpm/ml for 48 h at 42°C. Blots were washed at a stringency
of O.lx SCC, 0.1% SDS at room temperature as described
(9) and autoradiographed.
RESULTS
The Effect of Different Cationic Liposome-Encapsulated
p-Tubulin Targeted Antisense Oligonucleotides in Killing
Intracellular Leishmania Parasites—The p-tubulin-specific
antisense oligonucleotide sequence is shown in Fig. 1. We
investigated the effect of the antisense oligonucleotide
encapsulated in three different cationic liposomes using
CTAB, SA, DOTAP as cations and DOPE as the lipid. The
molar ratio used in this cationic liposome preparation is
4:1. The data in Table I show that the specific antisense oli-
gonucleotides encapsulated in cationic liposomes are effec-
tive in killing intracellular leishmania parasites with a
maximum effect at a concentration of 4 |xM of about 73.3 ±
GTCCTTTGCTAGAGTGCGTA
/3 -Tubulin 3'
Z3 mRNA
i i im i i i i i i immi
Antisanse CAGGAAACGATCTCACGCAT
Fig. 1. Oligonucleotide sequence targeted to the p-tubulin gene
of L. donovani. The sequences of the antisense and sense oligonu-
cleotides used for targeting are shown as a box. The vertical lines
show hybridization of the oligonucleotides and (3-tubulin.
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3, 80.0 ± 1, and 88.0 ± 2% for SA, CTAB, and DOTAP,
respectively. Compared to this, the free antisense oligonu-
cleotide at a concentration of 1 to 4 (xm is effective in sup-
pressing the parasite burden only about 22 to 28%. The
corresponding free sense oligonucleotides at a concentra-
tion of 1—4 \iM when used as controls, show insignificant
parasite burden suppression (6.7 to 9.7%). Another control
sense oligonucleotide (med RNA) with the sequence 5'CG-
CTATATAAGTATCAGTTT3' (Bangalore Genei, India) in
the concentration range of 1-4 (xM, suppressed the intrac-
ellular parasite load only about 5-6%. Free antisense oligo-
I I Untreated macrophoges
I///I Treated macrophages
100
80
40
20
7/.
1.0 2.0 4.0
Antisense Concentration (pM)
Fig. 2. Trypan blue exclusion test to investigate the toxicity of
antisense oligonucleotides. Macrophages (both untreated heat
killed and drug treated) were incubated in vitro with varying con-
centrations of antisense oligonucleotides for 1 h at 37°C. then 0.4%
of trypan blue solution was added, incubatd for 10 min, and % via-
bility was calculated.
nucleotides had no effect on the viability of macrophages
under these conditions (Fig. 2). From these results, it ap-
pears that there is a sequence-specific effect of antisense
oligonucleotides, and that delivery through cationic lipo-
somes increases their efficacy about 3.5 times. The choice of
cations for the delivery of antisense oligonucleotides may
also play a part as different cationic lipids showed different
efficacies (Table I).
Measurement of Intracellular fi-Tubulin Levels of L.
donovani (Dot-Blot Analysis)—Total RNA from infected
macrophages, antisense treated infected macrophages, L.
donovani parasites and from normal macrophages was sub-
jected to dot blot hybridization using a p-tubulin probe (Fig.
P I A j A4 M
I I I I I
A- tubulin —
I I I
A _
I I
Fig. 3. Autoradiogram of P-tubulin RNA levels (Dot-blot). Total
RNA from L. donovani parasites, normal macrophages, specific
sense and liposomal (CTAB:DOPE) antisense oligonucleotide—
treated infected macrophages were isolated and analyzed for p-tu-
bulin levels using specific radiolabelled (3-tubulin DNA as a probe.
The results of two different experiments are shown in different pan-
els. Upper panel: P, parasites; I, infected macrophages; Aj, liposomal
antisense 2 yM; A4, liposomal antisense 4 |xM; M, Macropahges.
Lower panel: P, I, A?, A4 and M represent the same samples as in the
upper panel; S2, sense oligonucleotde at 2 |xM; S4, sense oligonucle-
otide at 4 [xM.
TABLE I. Effect of p-tubulin-specific antisense oligonucleotides (20 mer) encapsulated in different cationic liposomes on the sup-
pression of intracellular parasite (L. donovani) load.
Treatment with p-tubulin-specific sense/antisense-oligonucleotides Composition of cationic liposomes 7 suppression
Free sense (MR), control (1 u.M)
Free sense (tubulin), control (1 |xM)
Free antisense (1 JJLM)
Liposomal antisense (1 u.M)
Liposomal antisense (1 |xM)
Liposomal antisense (1 |xM)
Free sense (MR), control (2 |xM)
Free sense (tubulin), control (2 |j.M)
Free antisense (2 u,M)
Liposomal antisense (2 p.M)
Liposomal antisense (2 u.M)
Liposomal antisense (2 u.M)
Free sense (MR), control (4 u.M)
Free sense (tubulin), control (4 (j.M)
Free antisense (4 JJLM)
Liposomal antisense (4 u.M)
Liposomal antisense (4 u.M)
Liposomal antisense (4 p.M)
CTAB:DOPE
SA:DOPE
DOTAP:DOPE
CTAB:DOPE
SADOPE
DOTAP:DOPE
CTAB:DOPE
SA:DOPE
DOTAP:DOPE
05.0 ± 1.5
06.7 ± 2.0
22.0 ± 2.0
50.0 ± 2.0
35.0 ± 3.0
55.0 ± 4.0
06.0 ± 1.7
08.2 ± 1.0
26.0 ± 3.0
66.0 ± 3.0
59.3 ± 4.0
69.3 ± 3.7
06.0 ± 2.0
09.7 ± 3.0
28.0 ± 2.0
80.0 ± 1.0
73.3 ± 4.0
88.0 ± 2.0
Infected macrophages were treated with p-tubulin-specific antisense oligonucleotides either in cationic liposomal or free form and with
their complementary free sense oligonucleotides at a concentration of 1-4 pM for 24 h at 37°C in a CO2 incubator. The cells were then again
kept in oligonucleotide-free medium for 18 h under the same experimental conditions. The samples were then processed to analyze the fate
of internalized parasites microscopically Results are mean ± SD (re = 3). Control sense oligonucleotides [both specific to medRNA (MR) and
tubulin] when used in cationic liposomal form (CTAB:DOPE) in the concentration range of 1-4 JJLM suppressed the intracellular parasite
load by about 10—12% at most.
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Sense
Antisense
2|xM
4(JLM
2|xM
4LLM
TABLE II. Densitometric scanning analysis of p-tubulin-spe-
cific RNA bands.
Oligonucleotides Concentration % inhibition of (3-tubulin RNA levels
14 ±2
17 ± 3
43 ± 1
56 ±4
Hybridization spots (Fig. 3) were quantified by scanning densitom-
etry in a Biorad GS 710 Densitometer. Background values corre-
sponding to uninfected macrophage control were subtracted. The
hybridization intensity of untreated infected macrophage samples
was taken as 100%. Mean and SD values (p < 0.005) for 3 indepen-
dent experiments are shown.
3). There was a dose-dependent decrease in (3-tubulin RNA
levels in the case of antisense oligonucleotide encapsulated
cationic liposome treatment (Table II). When compared
with the untreated infected control, the cationic lipo-some
mediated effect is greater (Fig. 3, upper panel). Sense oligo-
nucleotide treatment does not produce any inhibitory effect
at the p-tubulin RNA level (Fig. 3, lower panel). Therefore,
the mechanism of killing of intracellular L. donovani para-
sites upon (3-tubulin-targeted antisense oligonucleotide
treatment is probably due to the inhibition of p-tubulin
synthesis at the RNA level and thus the arrest of disease
progression inside the host macrophages. The levels of con-
trol RNAs specific for host macrophages, e.g. actin mRNA
and rRNA, were not altered by treatment with antisense
oligonucleotides (data not shown). This observations is in
keeping with the lack of toxicity of oligonucleotides shown
towards the host macropages (Fig. 2).
DISCUSSION
Antisense oligonucleotides are of potential interest for clini-
cal applications that would exploit their antiproliferative,
antiviral or antiparasitic properties (10). Antisense oligonu-
cleotides have also been reported to have little inhibitory
effect against HIV I in culture (11). Reports have already
appeared regarding the leishmaniacidal effect of cationic
liposome encapsulated antisense oligonucleotides targeted
to the miniexon sequence of L. donovani in vitro (4). Be-
cause such oligonucleotides are rapidly degraded in the
medium (12), investigations are on going to overcome this
problem. The two important approaches include (13-15): (i)
the modification of oligonucleotides with increased nuclease
resistance (16), which includes phosphorothioate oligonu-
cleotides and oligonucleotides with the sugar moiety ori-
ented in the a-configuration (17), (ii) the encapsulation of
oligonucleotides in cationic liposomes or immunoliposomes
(18, 19) to protect them against nuclease activity and to
increase the efficiency of delivery into cells.
In the present study, p-tubulin targeted antisense oligo-
nucleotides in different cationic liposomes have been found
to inhibit L. donovani parasite survival inside macrophages
when tested in vitro. Our results show a sequence-specific
effect of p-tubulin targeted antisense oligonucleotides in
killing L. donovani parasites. In comparison with free anti-
sense oligonucleotides at concentrations of 1—4 u,M, lipo-
some encapsulated antisense oligonucleotides show greater
leishmanicidal activity at the same concentration. The im-
proved efficacy of liposomal antisense oligonucleotides may
be due to their protection against nuclease activity and in-
creased cellular uptake.
The mechanism of oligonucleotide release from liposomes
has been studied previously and it has been seen that cat-
ionic liposome encapsulated antisense oligonucleotides are
phagocytosed and fused with parasitophorous vacuoles,
leading to increased intracellular antisense oligonucleotide
concentrations in comparison with that delivered in the
free form, in the vicinity of the parasites. The mode of entry
of antisense oligonucleotides into the amastigote form of
parasites is not clear. However, it has recently been re-
ported that the entry probably takes place through the
flageller pocket (20,21).
There are two mechanisms that can account for the
leishmanicidal effects induced by anti-P-tubulin oligonucle-
otides: (i) competition between the oligomers and the
machinery in charge of reading the mRNA born informa-
tion, thus blocking protein translation, and (ii) RNase H—
mediated degradation of the target. Only indirect indica-
tions suggest that RNase H could be involved in the anti-
sense effects in intact cells (2). Thus we designed our study
to examine the p-tubulin-RNA levels in the case of un-
treated infected macrophages and antisense-treated in-
fected macrophages. The Dot-blot experiment clearly shows
a dose-dependent decrease in the p-tubulin RNA level in
infected macrophages in the case of specific antisense treat-
ment. Liposome encapsulated antisense oligonucleotides
have been found to be more efficient in blocking p-tubulin
RNA levels. As it has been previously reported that liposo-
mal antisense oligonucleotides are taken up better by cells
(17) in vitro, they show an enhanced effect in blocking p-
tubulin RNA and also in suppressing the parasite burden.
Thus we can conclude that p-tubulin targeted antisense oli-
gonucleotides could be another specific antisense target in
addition to the miniexon sequence to suppress the parasitic
burden intracellularly.
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